Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05016440Withdrawn
Randomised, double-blind trial of lisinopril in Microalbuminuria and hypertension (HTN) (2 arms), sponsored by Eastern Virginia Medical School. Primary endpoint: Albumin Excretion Rate. Planned start Sep 2015; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05016440.